Carregant...

Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England

In England, during pandemic 2009 H1N1, vaccine efficacy and immunogenicity population studies in priority groups were rolled out in parallel to evaluate the pandemic vaccination programme. This provided a unique opportunity to compare immunogenicity and clinical protection in the same population and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yung, Chee-Fu, Andrews, Nick, Hoschler, Katja, Miller, Elizabeth
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579930/
https://ncbi.nlm.nih.gov/pubmed/23451097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0056844
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!